Structural requirements for potent human spermicidal activity of dual- function aryl phosphate derivative of bromo-methoxy zidovudine (compound WHI- 07)

Biology of Reproduction

Volumn 62, Issue 1, 2000, Pages 37-44

  D'Cruz, Osmond J ^a   Venkatachalam, Tarakad K ^a   Uckun, Fatih M ^a  

^a PARKER HUGHES INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 BROMO 5,6 DIHYDRO 6 METHOXY 3' AZIDOTHYMIDINE 5' (4 BROMOPHENYL)METHOXYALANINYL PHOSPHATE; NONOXINOL 9; SPERMICIDAL AGENT; UNCLASSIFIED DRUG; ZIDOVUDINE DERIVATIVE;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; SPERM; STRUCTURE ACTIVITY RELATION; UTERINE CERVIX EPITHELIUM;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; SIA;

EID: 0033970759     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod62.1.37     Document Type: Article

References (44)

1. Royce RA, Sena A, Cates W Jr. Cohen MS. Sexual transmission of HIV. N Engl J Med 1997; 336:1072-1078.
2. Quinn TC. Global burden of the HIV epidemic. Lancet 1996; 348: 99-106.
3. Ickovics JR, Yoshikawa H. Preventive interventions to reduce heterosexual HIV risk for women: current perspectives, future directions. AIDS 1998; 12(suppl A):S197-208.
4. Celum CL, Watts DH. HIV and women. In: Spach DH, Hooten TM (eds.), The HIV Manual. New York: Oxford University Press; 1996: 120-127.
5. Ward JW, Duchin JS. The epidemiology of HIV and AIDS in the United States. AIDS Clin Rev 1997; 98:1-45.
6. CDCP Update. US HIV and AIDS cases reported through December 1996. HIV/AIDS Surveillance Report 1997; 8:1-33.
7. Davis SF, Rosen DH, Steinberg S, Wortley PM, Karon JM, Gwinn M. Trends in HIV prevalence among childbearing women in the United States, 1989-1994. J Acquired Immune Defic Syndr Hum Retrovirol 1998; 19:158-164,
8. Sallio SD, Kurtzman JT, Radner AB. HIV infection in women: an escalating health concern. Am Fam Phys 1996; 54:1541-1548.
9. CDCP Update. Mortality attributable to HIV infection among persons aged 25-44 years - United States, 1994. MMWR 1996; 45:121-125.
10. Lange JMA, Karam M, Piot P. Boost for vaginal microbicides against HIV. Lancet 1993; 341:1356-1359.
11. Cookson C. WHO to concentrate HIV strategy on vaginal microbicide. Br Med J 1993; 307:1375-1376.
12. Elias CJ, Heise LL. Challenges for the development of female-controlled vaginal microbicides. AIDS 1994; 8:1-9.
13. Potts M. The urgent need for a vaginal microbicide in the prevention of HIV transmission. Am J Public Health 1994; 84:890-891 [Editorial].
14. Gwinn M, Wortley PM. Epidemiology of HIV infection in women and newborns. Clin Obstet Gynecol 1996; 39:293-304.
15. Chantler E. Vaginal contraception: some current concerns. Br J Fam Plann 1992; 17:118-119.
16. OTC Panel. Vaginal contraceptive drug products for over-the-counter human use. Fed Reg 1980; 45:82014-82049.
17. Rekart ML. The toxicity and local effects of the spermicide nonoxynol-9. J Acquired Immune Defic Syndr 1992; 5:425-427.
18. Roddy RE, Cordero M, Cordero C, Fortney JA. A dosing of nonoxynol-9 and genital irritation. Int J STD HIV 1993; 4.165-170.
19. Stafford MK, Ward H, Flanagan A, Rosenstein IJ, Taylor-Robinson D, Smith JR, Weber J, Kitchen VS. A safety study of nonoxynol-9 as a vaginal microbicide: evidence of adverse effects. J Acquired Immune Defic Syndr Hum Retrovirol 1998; 17:327-331.
20. Rosenstein IJ, Stafford MK, Kitchen VS, Ward H, Weber JN, Taylor-Robinson D. Effect of normal vaginal flora of three intravaginal microbicidal agents potentially active against human immunodeficiency virus type 1. J Infect Dis 1998; 177:1386-1390.
21. Kreiss J, Ngugi E, Holmes K, Ndinya-Achola J, Waiyaki P, Roberts PL, Ruminjo I, Sajabi R, Kimata J, Fleming TR, Anzala A, Hoton D, Pummer F. Efficacy of nonoxynol-9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes. JAMA 1992; 268:477-482.
22. Mati JK, Hunter DF, Maggwa BN, Tukei PM. Contraceptive use and the risk of HIV infection in Nairobi, Kenya. Int J Obstet Gynecol 1995; 48:61-67.
23. Weir SS, Roddy RE, Zeking L, Feldblum PJ. Nonoxynol-9 use, genital ulcers, and HIV infection in a cohort of sex workers. Genitourin Med 1995; 71:78-81.
24. Schill WB, Wolf HH. Ultrastructure of human spermatozoa in the presence of the spermicide nonoxynol-9 and a vaginal contraceptive containing nonoxynol-9. Andrologia 1981; 13:42-49.
25. Wilborn WH, Hahn DW, McGuire JJ. Scanning electron microscopy of human spermatozoa after incubation with the spermicide nonoxynol-9. Fertil Steril 1983; 39:717-719.
26. Bourinbaiar AS, Fruhstorfer EC. Efficacy of nonoxynol-9 from an in vitro point of view. AIDS 1996; 10:558-559.
27. Wittkowiski KM, Susser E, Dietz K. The protective effect of condoms and nonoxynol-9 against HIV infection. Am J Public Health 1998; 88:590-596.
28. Hira SK, Feldblum PJ, Kamanga J, Mukelabai G, Weir SS, Thomas JC. Condom and nonoxynol-9 use and the incidence of HIV infection in serodiscordant couples in Zambia. Int J STD AIDS 1997; 8:243-250.
29. Roddy RE, Zeking L, Ryan KA, Tamoufe U, Weir SS, Wong EL. A controlled trial of nonoxynol-9 film to reduce male-to-female transmission of sexually transmitted diseases. N Engl J Med 1998; 339: 504-510.
30. Phillips DM. The role of cell-to-cell transmission in HIV infection. AIDS 1994; 8:719-731.
31. Quayle AJ, Xu C, Mayer KH, Anderson DJ. T Lymphocytes and macrophages, but not motile spermatozoa, are a significant source of human immunodeficiency virus in semen. J Infect Dis 1997; 176:960-968.
32. Zhang H, Dornadula G, Beumont M, Livornese L, Van Uitert B, Henning K, Pomerantz RJ. Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy. N Engl J Med 1998; 339:1803-1809.
33. D'Cruz OJ, Venkatachalam TK, Zhu Z, Shih M-J, Uckun FM. Bromomethoxy and aryl phosphate derivatives of azidothymidine are dual-function spermicides with potent anti-HIV activity. Biol Reprod 1998; 59:503-515.
34. Jan ST, Zhu Z, Tai HL, Shih MJ, Venkatachalam TK, Uckun FM. AZT-5′-(p-bromophenyl methoxyalaninyl phosphate) as a potent and non-toxic anti-human immunodeficiency virus agent. Antivir Chem Chemother 1999; 10:47-52.
35. Jan S-T, Shih M-J, Venkatachalam TK, D'Cruz OJ, Chen C-L, Uckun FM. Synthesis of dual-function (5R,6R)-and (5S,6S)-5-bromo-6-methoxy-5,6-dihydro-AZT-5′-(para-bromophenyl methoxyalaninyl phosphate) as novel spermicidal and anti-HIV agents. Antivir Chem Chemother 1999; 10:39-46.
36. D'Cruz OJ, Shih M-J, Yiv SH, Chen C-L, Uckun FM. Synthesis, characterization, and preclinical formulation of a dual-action phenyl phosphate derivative of bromo-methoxy zidovudine (compound WHI-07) with potent anti-HIV and spermicidal activities. Mol Hum Reprod 1999; 5:421-432.
37. D'Cruz OJ, Zhu Z, Yiv SH, Chen C-L, Waurzyniak B, Uckun FM. WHI-05, a novel bromo-methoxy substituted phenyl phosphate derivative of zidovudine, is a dual-action spermicide with potent anti-HIV activity. Contraception 1999; 59:319-331.
38. D'Cruz OJ, Uckun FM. Novel derivatives of phenethyl-5-bromopyridylthiourea and dihydroalkoxybenzyloxopyrimidine are dual-function spermicides with potent anti-HIV activity. Biol Reprod 1999; 60: 1419-1428.
39. 2-Integrin (CD11b/CD18) is the primary adhesive glycoprotein complex involved in neutrophil-mediated immune injury to human sperm. Biol Reprod 1995; 53:1118-1130.
40. D'Cruz OJ, Ghosh P, Uckun FM. Spermicidal activity of metallocene complexes containing vanadium(IV) in humans. Biol Reprod 1998; 58:1515-1526.
41. D'Cruz OJ, Ghosh P, Uckun FM. Spermicidal activity of chelated complexes of bis cyclopentadienyl vanadium complexes. Mol Hum Reprod 1998; 4:683-693.
42. D'Cruz OJ, Dong Y, Uckun FM. Spermicidal activity of oxovanadium(IV) complexes of 1,10-phenanthroline, 2,2′-bipyridyl, 5′-bromo-2′-hydroxyacetophenone and derivatives in humans. Biol Reprod 1999; 60:435-444.
43. Uckun FM, Chelstrom LM, Ahlgren-Tuel L, Dibirdik I, Irvin JD, Langlie M-C, Myers DE. TXU (Anti-CD7)-pokeweed antiviral protein as a potent inhibitor of human immunodeficiency virus. Antimicrob Agents Chemother 1998; 42:383-388.
44. Zarling JM, Moran PA, Haffar O, Sias J, Richman DD, Spina CA, Myers DE, Kuebelbeck Y, Ledbetter JA, Uckun FM. Inhibition of HIV replication by pokeweed antiviral protein targeted to CD4+ cells by monoclonal antibodies. Nature 1990; 347:92-95.